Lyme disease and related disorders, collectively known as Lyme borreliosis, are caused by the spirochete Borrelia burgdorferi (7, 9, 10, 13, 16) . Rodents and other animals are the major reservoirs of the spirochete (1, 8) ; ixodid ticks are the primary vectors (1, 9, 10) . After exposure of a human to an infected tick, B. burgdorferi gains access to the blood and lymphatic circulation, and a systemic illness ensues. The development of a characteristic expanding erythematous Minnesota mouse (MM) isolate, for protective antibodies. Spirochetes were cultivated in Barbour-Stoenner-Kelly (BSK) medium (4) at 30°C. Rabbits received weekly intravenous injections of 108 viable cells washed twice with 0.01 M phosphate-buffered saline (pH 7.5). Serum was harvested 2 to 3 weeks after the final injection, and the antibody titer was determined by the indirect fluorescent-antibody assay (6) . Rabbits immunized with the B. burgdorferi HSF isolate skin lesion, erythema chronicum migrans, at the site of the tick bite is an early and diagnostic feature of the disease (17) . Some patients develop the chronic forms of the disease involving the joint synovia (arthritis [17] ), the skin (acrodermatitis chronica atrophicans [11] ), and the nervous system (Bannwarth's syndrome [3] ). These forms of the disease are associated with the persistence of the spirochetes in the host (2, 14, 15, 18 neys and spleens were cultured. Each hamster organ was placed in 6 ml of BSK medium and homogenized with a Stomacher Lab-Blender (Tekmar Co., Cincinnati, Ohio). After the larger tissue debris was allowed to settle, duplicate 1:10 dilutions of the supernatant were made in the isolation medium. Isolation medium was prepared by the addition of 0.15% agarose (SeaKem LE; FMC Corp., Marine Colloids Div., Rockland, Maine) to BSK medium. Cultures were examined for spirochetes by dark-field microscopy after 3 weeks of incubation at 30°C.
Control hamsters which received 1 ml of pooled normal rabbit serum were not protected from challenge with 1,000
ID50s of the HSF isolate of B. burgdorferi. Of the 10 hamsters which received normal rabbit serum, 10 were culture positive (Table 1 ). In contrast, hamsters which received as little as 0.0125 ml of anti-B. burgdorferi (HSF isolate) serum were fully protected from challenge ( Table 1) . The MM isolate also elicited the formation of protective antibodies. Normal rabbit serum (0.5 ml) did not protect hamsters from challenge with 108 cells of the MM isolate. However, 0.5 ml of anti-B. burgdorferi (MM isolate) serum provided 100% protection against challenge with the MM isolate.
The immunogenic specificity of these two isolates from different geographical areas was investigated by crossprotection studies. Of hamsters passively immunized with 0.1 ml of anti-B. burgdorferi (HSF isolate) serum, 80% were resistant to challenge with the MM isolate ( Table 1) . Comparable results were observed with hamsters which received 0.5 ml of anti-B. burgdorferi (MM isolate) serum and were challenged with 1,000 ID50s of the HSF isolate. Of these hamsters, 100% were resistant to challenge ( Table 1) .
The results of the passive immunization studies suggest that circulating antibodies can play a major role in resistance to B. burgdorferi infection. The cross-protection passiveimmunization studies with rabbit antisera to isolates from two geographically different endemic areas of Lyme disease suggest that both isolates are similar in their protective antigen composition. Our cross-protection studies are in agreement with the report of Barbour et al. (5) . They studied the antigens of a number of B. burgdorferi isolates from the United States and found their antigenic composition to be quite homogeneous.
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